Literature DB >> 17203518

Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C.

Tadashi Takeda1, Takahiro Yasuda, Yuji Nakayama, Mika Nakaya, Megumi Kimura, Mariko Yamashita, Ayumi Sawada, Koji Abo, Setsuko Takeda, Hiroki Sakaguchi, Susumu Shiomi, Hitoshi Asai, Shuichi Seki.   

Abstract

AIM: To evaluate the method of noninvasive transient elastography for assessment of histological stage of liver fibrosis in patients with chronic hepatitis C (CHC).
METHODS: Two hundred and thirty-seven patients with CHC were included in this study. Liver biopsy was performed under ultrasonography on 217 of the patients, excluding twenty with clear clinical evidence of liver cirrhosis. Fifty subjects without liver disease were enrolled as a control group (stage 0). Twenty-five patients with sustained virological response (SVR) to interferon (IFN) therapy were also enrolled. These patients underwent liver biopsy before IFN therapy. Examination of liver stiffness (LS) was performed by elastography.
RESULTS: Medians (50% levels) of LS were 4.1 (3.5-4.9), 6.3 (4.8-8.5), 8.8 (6.8-12.0), 14.6 (10.5-18.6), and 22.2 (15.4-28.0), respectively, in the fibrosis stages 0-4 (P < 0.001). LS was significantly correlated with four serum fibrosis markers. LS values in patients with SVR were 3.8 (3.5-5.6), 5.2 (4.4-6.8), 6.8 (6.1-7.6), and 6.1 (3.6-7.9), respectively, in the fibrosis stages 1-4. In all stages, LS for patients with SVR was significantly lower than that for patients who did not undergo IFN therapy. LS was significantly correlated with serum concentrations of hyaluronic acid, type IV collagen, type IV collagen 7S, and type III procollagen N peptide.
CONCLUSION: LS correlated well with the histological stage of fibrosis. Changes in liver fibrosis stage may thus be estimated noninvasively using transient elastography.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17203518      PMCID: PMC4087540          DOI: 10.3748/wjg.v12.i48.7768

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  Liver biopsy.

Authors:  A A Bravo; S G Sheth; S Chopra
Journal:  N Engl J Med       Date:  2001-02-15       Impact factor: 91.245

Review 2.  Appropriateness of liver biopsy.

Authors:  T Poynard; V Ratziu; P Bedossa
Journal:  Can J Gastroenterol       Date:  2000-06       Impact factor: 3.522

3.  Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy.

Authors:  R D Soloway; A H Baggenstoss; L J Schoenfield; W H Summerskill
Journal:  Am J Dig Dis       Date:  1971-12

4.  Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver.

Authors:  B Maharaj; R J Maharaj; W P Leary; R M Cooppan; A D Naran; D Pirie; D J Pudifin
Journal:  Lancet       Date:  1986-03-08       Impact factor: 79.321

5.  Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Authors:  Laurent Castéra; Julien Vergniol; Juliette Foucher; Brigitte Le Bail; Elise Chanteloup; Maud Haaser; Monique Darriet; Patrice Couzigou; Victor De Lédinghen
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

6.  Radioimmunoassay for type III procollagen peptide and its application to human liver disease.

Authors:  H Rohde; L Vargas; E Hahn; H Kalbfleisch; M Bruguera; R Timpl
Journal:  Eur J Clin Invest       Date:  1979-12       Impact factor: 4.686

7.  Comparison of sulphated glycosaminoglycan and hyaluronate synthesis and secretion in cultured hepatocytes, fat storing cells, and Kupffer cells.

Authors:  A M Gressner; S Schäfer
Journal:  J Clin Chem Clin Biochem       Date:  1989-03

8.  Increased serum levels of hyaluronate in liver disease.

Authors:  A Engström-Laurent; L Lööf; A Nyberg; T Schröder
Journal:  Hepatology       Date:  1985 Jul-Aug       Impact factor: 17.425

9.  The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease.

Authors:  A Frei; A Zimmermann; K Weigand
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

10.  Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

Authors:  Laurent Sandrin; Bertrand Fourquet; Jean-Michel Hasquenoph; Sylvain Yon; Céline Fournier; Frédéric Mal; Christos Christidis; Marianne Ziol; Bruno Poulet; Farad Kazemi; Michel Beaugrand; Robert Palau
Journal:  Ultrasound Med Biol       Date:  2003-12       Impact factor: 2.998

View more
  14 in total

Review 1.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 2.  Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.

Authors:  Masaru Enomoto; Hiroyasu Morikawa; Akihiro Tamori; Norifumi Kawada
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  Transient Elastography-Based Liver Stiffness Age-Dependently Increases in Children.

Authors:  Daisuke Tokuhara; Yuki Cho; Haruo Shintaku
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

4.  Performance of liver stiffness measurements by transient elastography in chronic hepatitis.

Authors:  Giovanna Ferraioli; Carmine Tinelli; Barbara Dal Bello; Mabel Zicchetti; Raffaella Lissandrin; Gaetano Filice; Carlo Filice; Elisabetta Above; Giorgio Barbarini; Enrico Brunetti; Willy Calderon; Marta Di Gregorio; Roberto Gulminetti; Paolo Lanzarini; Serena Ludovisi; Laura Maiocchi; Antonello Malfitano; Giuseppe Michelone; Lorenzo Minoli; Mario Mondelli; Stefano Novati; Savino F A Patruno; Alessandro Perretti; Gianluigi Poma; Paolo Sacchi; Domenico Zanaboni; Marco Zaramella
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

5.  In vivo quantification of liver stiffness in a rat model of hepatic fibrosis with acoustic radiation force.

Authors:  Michael H Wang; Mark L Palmeri; Cynthia D Guy; Liu Yang; Laurence W Hedlund; Anna Mae Diehl; Kathryn R Nightingale
Journal:  Ultrasound Med Biol       Date:  2009-08-14       Impact factor: 2.998

6.  The accuracy of sonography in predicting steatosis and fibrosis in chronic hepatitis C.

Authors:  Chien-Hua Chen; Shang-Tao Lin; Chi-Chieh Yang; Yung-Hsiang Yeh; Chien-Long Kuo; Chiu-Kue Nien
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

7.  Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis.

Authors:  Tamara Alempijevic; Miodrag Krstic; Rada Jesic; Ivan Jovanovic; Aleksandra Sokic Milutinovic; Nada Kovacevic; Slobodan Krstic; Dragan Popovic
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

8.  How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements.

Authors:  Hui Won Dang; Seung Up Kim; Jun Yong Park; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Young Nyun Park; Eun Hee Choi; Do Young Kim
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

9.  Transient Elastography-Based Liver Profiles in a Hospital-Based Pediatric Population in Japan.

Authors:  Yuki Cho; Daisuke Tokuhara; Hiroyasu Morikawa; Yuko Kuwae; Eri Hayashi; Masakazu Hirose; Takashi Hamazaki; Akemi Tanaka; Tomoyuki Kawamura; Norifumi Kawada; Haruo Shintaku
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

10.  Liver stiffness using transient elastography is applicable to canines for hepatic disease models.

Authors:  Antonio Rivero-Juárez; Juan Morgaz; Angela Camacho; Pilar Muñoz-Rascón; Juan Manuel Dominguez; Raquel Sánchez-Céspedes; Julián Torre-Cisneros; Antonio Rivero
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.